FOR IMMEDIATE RELEASE

September 8, 2010 (Irvine, California) - BioMedGPS, a provider of real-time online business intelligence and dynamic decision-making tools for life science executives, reports that the first silo of its comprehensive “SmartTRAK Spine” Online Business Intelligence System focused on current and emerging vertebroplasty and vertebral augmentation/kyphoplasty technologies is now available.   

The US market for VCF products will reach $544 million in 2010 and grow at a rate of 8.8% to an estimated $788 million in 2014, according to SmartTRAK analysis. The SmartTRAK Spine VCF silo currently profiles 34 US and OUS companies – more than 75% of those privately held -- and close to 50 products on the market or under development, with more companies and products being added regularly. Products profiled in detail include access and injection systems for delivery of bone cements, inflatable bone tamps and implantable devices. (Profiles of bone replacement products used in VCF are currently available in the SmartTRAK OrthoBio Module).  Also provided is a detailed Market Profile with 5-year US sales and procedure volumes forecasts, competitive market shares, and regulatory and reimbursement information.  

“With the movement of vertebroplasty to an outpatient setting, its lower treatment cost when compared to vertebral augmentation/kyphoplasty, and industry-wide pricing and reimbursement pressure, we forecast that vertebroplasty will account for the majority of all VCF procedures by 2014 while prices for vertebral augmentation/kyphoplasty products will drop significantly.” reports Sharon O’Reilly, Founder, President and CEO of BioMedGPS, the developer of the SmartTRAK Online Business Intelligence System. “The spine market is undergoing unprecedented market slowdown that is expected to continue for the next five years. More than ever, VCF players and others involved in the spine industry need to stay on top of every development affecting their business and with SmartTRAK, key data can be accessed within seconds.”

Other silos of the extensive “SmartTRAK Spine” Online Business Intelligence System soon to be released in addition to VCF include Fusion, Dynamic Posterior Stabilization, Motion Preservation, Decompression and Vertebral Body Replacement. In all, over 300 privately held and public companies from around the world and several hundred spinal devices will be tracked and continuously updated in SmartTRAK, along with 5-year market analyses for each silo.  In addition, the SmartTRAK Orthobiologics Database is available in its entirety which includes profiles of more than 450 cartilage, meniscus, bone, soft tissue and disc repair and replacement technologies, along with joint fluid replacement.

SmartTRAK is an innovative real-time and interactive market intelligence platform designed to help medical device executives make faster, smarter and more cost-effective business decisions. Designed to replace print market and technology reports widely used in the industry today, the powerful SmartTRAK Online Business Intelligence will transform the delivery of medical device business information from static data to real-time information and analysis. SmartTRAK tracks emerging companies, competitive developments, regulatory approvals, and strategic alliances, and presents this information in concise individual market, company and product profiles that are updated as industry developments occur to provide users with a current "snapshot" of a medical device industry segment. SmartTRAK allows users to search, sort, store and share information—increasing the productivity of business/corporate development, marketing, market research, R&D and other device executives, and saving companies money.

Contact BioMedGPS to schedule a live WebEx demo with your team.

About BioMedGPS, LLC
Founded by Sharon O'Reilly, Founder and former CEO of Medtech Insight, BioMedGPS provides online business intelligence and dynamic decision-making tools specifically designed for life science executives. In addition to SmartTRAK, the Company also holds focused Strategic Partnering and Investment Conferences, and provides medical device market expertise via its Consulting Group.

CONTACT:
Sharon O’Reilly or Tracy Neilssien
949-559-5511
This e-mail address is being protected from spambots. You need JavaScript enabled to view it
www.biomedgps.com